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Abstract
Over 200 mutations in the retina specific member of the ATP-binding cassette transporter superfamily
(ABCA4) have been associated with a diverse group of human retinal diseases. The disease mechanisms, and
genotype–phenotype associations, nonetheless, remain elusive in many cases. As orthologous genes are
commonly mutated in canine models of human blinding disorders, canine ABCA4 appears to be an ideal
candidate gene to identify and study sequence changes in dogs affected by various forms of inherited retinal
degeneration. However, the size of the gene and lack of haplotype assignment significantly limit targeted
association and/or linkage approaches. This study assessed the naturally observed sequence diversity of
ABCA4 in the dog, identifying 80% of novel variations. While none of the observed polymorphisms have
been associated with blinding disorders to date, breed and potentially disease specific haplotypes have been
identified. Moreover, a tag SNP map of 17 (15) markers has been established that accurately predicts common
ABCA4 haplotypes (frequency > 5%) explaining >85% (>80%) of the observed genetic diversity and will
considerably advance future studies. Our sequence analysis of the complete canine ABCA4 coding region will
clearly provide a baseline and tools for future association studies and comparative genomics to further
delineate the role of ABCA4 in canine blinding disorders.
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Abstract
Over 200 mutations in the retina specific member of the ATP-binding cassette transporter super-
family (ABCA4) have been associated with a diverse group of human retinal diseases. The disease
mechanisms, and genotype–phenotype associations, nonetheless, remain elusive in many cases. As
orthologous genes are commonly mutated in canine models of human blinding disorders, canine
ABCA4 appears to be an ideal candidate gene to identify and study sequence changes in dogs affected
by various forms of inherited retinal degeneration. However, the size of the gene and lack of haplotype
assignment significantly limit targeted association and/or linkage approaches. This study assessed
the naturally observed sequence diversity of ABCA4 in the dog, identifying 80% of novel variations.
While none of the observed polymorphisms have been associated with blinding disorders to date,
breed and potentially disease specific haplotypes have been identified. Moreover, a tag SNP map of
17 (15) markers has been established that accurately predicts common ABCA4 haplotypes (frequency
> 5%) explaining >85% (>80%) of the observed genetic diversity and will considerably advance
future studies. Our sequence analysis of the complete canine ABCA4 coding region will clearly
provide a baseline and tools for future association studies and comparative genomics to further
delineate the role of ABCA4 in canine blinding disorders.
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Introduction
The ATP-binding cassette (ABC) transporter A-subfamily consists of a large number of
transporter proteins, many of which are associated with inherited disorders (Holland et al.
2003; Albrecht and Viturro 2007). Only one member, ABCA4, is specific to the retina, and is
expressed in the photoreceptor outer segments (Sun and Nathans 1997). More than 500 putative
mutations are proposed for ABCA4 in humans. To date, over 200 of these have been implicated
with disease phenotypes (OMIM #601691), the vast majority of which are linked to Stargardt
disease (STGD), a juvenile form of macular degeneration (Sun et al. 2000; Webster et al.
2001; Klevering et al. 2005). Individual mutations, however, also cause cone-rod dystrophy
(Ducroq et al. 2002), and retinitis pigmentosa (RP) (Cremers et al. 1998); involvement with
age-related macular degeneration has been suggested by several reports (Allikmets et al.
1997; Shroyer et al. 2001). Many of these studies are based on allele association with the retinal
phenotype, yet the contribution of individual sequence changes and the mechanism leading
from mutation to disease is often unclear.
In humans, individual defects are frequently limited to small cohorts or families, barely
sufficient to securely associate genotype to phenotype (Stone 2003), and in-depth clinical
investigations are limited to non-invasive procedures that depend on patient availability
(Kitiratschky et al. 2008; Cideciyan et al. 2009). Progress in understanding the disease has
resulted from a series of elegant biochemical and expression studies (Sun et al. 1999, 2000;
Sun and Nathans 2001) demonstrating that the ABCA4 candidate ligand is all-trans-retinal, a
chromophore implicated in facilitating light damage of the retina (Sun et al. 1999). In short,
by transporting either all-trans-retinal or the Schiff base adduct of all-trans-retinal and
phosphatidylethanolamine from the luminal to the cytosolic disc membrane, ABCA4 likely
accelerates the reduction to all-trans-retinol, which is thought to be the rate-limiting step in
the visual cycle.
Development of an Abcr knockout mouse provided additional insights into the role of this
pathway in vivo, but failed to display all features of the human disease (Weng et al. 1999;
Molday et al. 2009). Notably, the murine model accumulates A2E deposits, a major lipofuscin
fluorophore and toxic all-trans-retinal derivate, in the retinal pigment epithelium (RPE), which
can be blocked through administration of isotretinoin (Radu et al. 2003). Since accumulation
of lipofuscin pigments is assumed to be the primary pathologic defect in Stargardt disease,
these studies grant hope for potential therapeutic intervention. Retinal degeneration, however,
is not reproduced in pigmented abca4−/− strains, and is difficult to distinguish from light and/
or age dependent damage in albino mice (Radu et al. 2008). While progress has been achieved
by addressing these questions by in vitro experiments (Liu et al. 2008), to date, there are no
other animal models available to study the specific role of ABCA4 mutations on RPE and/or
photoreceptor degeneration.
Thus far, studies in canine models based on few polymorphic markers in informative families,
have excluded ABCA4 from association with two autosomal recessive, non-allelic forms of
canine cone-rod degeneration (crd1, crd2) (Kijas et al. 2004) and cone-rod dystrophy in the
standard wire haired dachshund (Wiik et al. 2008). The large size of the ABCA4 coding region
and the population structure of the dog that is segregated into genetically isolated breeds
(Quignon et al. 2007) pose significant limitations for the identification of variations that are
potentially important in only a few breeds. Thus, a study excluding ABCA4 from association
with various forms of progressive retinal atrophy (PRA), the canine RP homologous group of
diseases, in 17 breeds was based on identification of only 18 polymorphisms by SSCP
(Lippmann et al. 2006). While association studies would be more appropriate for studies of
ABCA4 in the dog, these rely on identification and availability of representative markers. This
study provides the first in-depth analysis on sequence diversity of ABCA4 in the dog, providing
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a total of 41 high frequency (>10%) markers in exons and intronic flanking region, resulting
in 17 tag SNPs. In addition, several breed-specific variants and rare alleles were identified that
are suitable for follow-up investigations in individual breeds. The current data set establishes
a baseline for the expected variation of ABCA4 in the dog and, therefore, enables targeted
association studies in the future.
Methods
Animal samples
Blood from dogs with autosomal recessive retinal degeneration, collectively referred to as
progressive retinal atrophy (PRA), was collected previously and stored after consent of the
owners. All animals were examined either by one of the two authors (GDA, GMA) or
collaborating board certified veterinary ophthalmologists, and diagnosis was verified in all
cases based on the breed-specific age of onset for retinal disease after exclusion of known
mutations [progressive rod-cone degeneration (Zangerl et al. 2006), rod-cone dysplasias (Suber
et al. 1993; Kukekova et al. 2009). These include breeds for which (a) the mode of inheritance
is known, but insufficient cases for genome wide association studies are available (AKI, BUM,
ESS, GOS, GSH, GSP, PAP, TIS, TT; see Table 1 for details on breed abbreviations); (b) only
isolated cases were reported, and no literature is available or the mode of inheritance is not yet
defined (e.g. EMD: not defined, SCW: no literature); (c) other retinal disorders have been noted
as segregating in the breed, but have been excluded as causative in the respective individuals
(BRI, CSNB; MSH, Type A-PRA); (d) other mutations are known that may interact with or
modify a different disease gene (MLD). In total, 26 affected animals representing 23 known
PRA breeds were entered into the current study (Table 1). Due to selection criteria (animals
born to unaffected parents) and/or based on previous studies, mode of inheritance was
considered autosomal recessive for all cases enrolled in the study (Aguirre and Acland 2006).
Unrelated control animals for PRA breeds were included, if available, as part of our archived
sample resource (ADT, AKI, BAS, BMD, GIT, IGH, PAP, TT). In addition, three unrelated
breeds (BOT, HUS, RRB) were added to address allele frequencies of sequence changes in a
wider spectrum of dog breeds, and potentially correct for association by breed rather than
disease. Thus, a total of 12 control animals from 11 different breeds were used (Table 1).
Exon screening
DNA was extracted from 200 μl total blood using QIAmp DNA Mini Kit (Qiagen) according
to the manufacturer's protocol. PCR primers were designed using Vector NTI™ v.10.3.0
software package based on comparison of the canine ABCA4 cDNA sequence
(NM_001003360) to the dog genome draft (http://www.genome.gov/12511476, version May
2005) to primarily amplify exonic sequences, including small introns in selected cases (Suppl.
Table 1). PCR products resulting from standard amplification were sequenced in both
directions using PCR primers on an ABI capillary sequencer at the University of Pennsylvania
core facility after purification with either QIAquick Gel Extraction Kit (Qiagen) or QIAquick
PCR Purification Kit (Qiagen).
Data analysis
Sequences were analyzed with the Sequencher® v.4.7 software; observed polymorphisms were
placed on the canine genome draft sequence (http://genome.ucsc.edu/, version May 2005), and
compared to the Broad SNP set (Lindblad-Toh et al. 2005). Allele frequencies were calculated
manually over the complete data set, haplotype analysis and identification of tag SNPs were
performed with the HapBlock software (Zhang et al. 2005). Haplotype structure was evaluated
based on common haplotypes (frequency > 5%) to explain the majority of observed variation
(80 and 85%, respectively). Population pair-wise FST's were computed using Arlequin v.3.1
(Excoffier et al. 2005), and further analyzed for statistical significance between affected and
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control animals and different breeds on a global and locus-by-locus basis using analysis of
molecular variance (AMOVA). Breed and disease status was taken into account for analysis
of polymorphisms and enabled identification of dog specific ABCA4 haplotypes.
Results
ABCA4 population structure
Genomic variation—A total of 38 dogs from 26 different breeds (Table 1) were sequenced
each for 16,484 bp of the complete ABCA4 coding region and flanking introns. Overall, these
data present 13% coverage of the roughly 128,000 bp genomic ABCA4 region. The analyzed
sequence harbored 88 sequence changes (Suppl. Table 2) in comparison to the canine genome
draft sequence (http://genome.ucsc.edu/, version May 2005), only 18 of which had previously
been reported; novel variants were submitted to the dbSNP data base (NCBI ss# 244242169–
244242238). This predicts an average variation of one polymorphism/400 bp within the
ABCA4 coding region (total 17 polymorphisms; 14 transitions, 3 transversions), and an almost
threefold increase in the variation for adjacent non-coding areas of the gene. In detail, these
changes consist of 60 transitions, 24 transversions, 2 deletions, and 2 insertions. Nonetheless,
only 34 polymorphisms are shared in more than three different breeds (Suppl. Table 2, multiple
breeds), and almost half (40) of the polymorphisms have a rare allele frequency of <5% in the
data set. While these are potentially unfavorable markers for large population screens, rare
alleles are commonly associated with disorders and/or specific to certain dog breeds.
Haplotype analysis—Due to the size of the ABCA4 gene, the most robust haplotype
structure, explaining the majority, >85% (>80%), in the diversity of common haplotypes
(frequency > 5%), was obtained by dividing the complete data set into 9 (6) blocks (Suppl.
figure 1). In general, two haplotypes were observed at high frequency (>10%) for individual
blocks, with higher variability predicting up to four common haplotypes for 5′ exons (Suppl.
figure 1, block 1 and 2). These data identified 17 (15) tag polymorphisms (Table 2, Suppl.
figure 1, Suppl. Table 2), which enable prediction of ABCA4 haplotypes with the same degree
of certainty obtained from a complete genomic exon scan and are the recommended markers
for future ABCA4 population screens.
AMOVA was applied to test for genetic distance among breeds from the total data set resulting
in only marginal significance (p = 0.049 ± 0.006). Accordingly, only two pairs of breeds could
be distinguished applying a pair-wise comparison between breeds; BAS from GIT, and HUS
from MSH. Particular attention was given to 17 polymorphisms located in the coding region
(Suppl. Table 3). Haplotype prediction using Arlequin v3.1 estimated up to 31 possible
chromosomes in the data set. A single haplotype (Suppl. Table 3, haplotype 14), however, is
observed at high frequency (>10%), and over 20% of the chromosomes are only observed once
(frequency 0.01) in the data set.
ABCA4 and PRA
Sequence variation—While the main focus of this study aimed to identify haplotype
structure and develop screening sets for association studies in dog breeds affected with PRA,
five sequence variations identified in affected animals were considered for association with
disease. Three heterozygous nucleotide changes (Suppl. Table 2, Suppl. figure 1; 58129706,
58152042, and 58174454) were observed in only one affected dog of the ADT, EMD, and
MLD breeds, respectively. The polymorphism specific to the ADT was not present in the non-
affected control animal; no control animals were available for the other two breeds. The MLD,
on the other hand, is homozygous affected for the RPGRIP1 mutation (Mellersh et al. 2006),
suggesting that the observed polymorphism, at best, may be a modifier for disease. These
ABCA4 sequence variations cannot be excluded with certainty from association with disease.
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Another heterozygous polymorphism in the 5′UTR region of an affected BMD (Suppl. Table
2, Suppl. figure 1; 58112910) was examined further in 12 non PRA-affected BMD, and showed
an allele frequency of ~7% in this population (data not shown). The PRA-affected GSP was
homozygous for a single polymorphism (Suppl. Table 2, Suppl. figure 1; 58124361) in intron
4. This polymorphism was subsequently typed in nine non-affected animals from the same
breed, and shown to be breed specific (70% allele frequency), but no linkage with disease could
be established (data not shown).
Only five of the identified polymorphisms cause changes in the amino acid (aa) sequence (Table
3; 58168353, 58180284, 58198327, 58207091, 58216455). Three of these have previously
been excluded from causative association with PRA (Kijas et al. 2004; 58168353, 58198327,
58216455). Although the remaining two changes are conserved in published ABCA4 sequences
of other species (Table 3), distribution in affected and non-affected animals within the present
data set excludes them from association with retinal degeneration (Suppl. figure 1, Suppl. Table
3).
Disease haplotypes—Low frequency SNPs observed in one or a few individuals only
contributed to rare haplotypes predicted by HapBlock (Suppl. figure 1). Thus, the affected GOS
is the only individual heterozygous at four different polymorphic positions (58167425,
58182988, 58190633, 58231826) not present in normal dogs, but disease association can be
excluded based on the presumed recessive nature of the trait in the breed. The same applies to
another polymorphism shared between this breed and a PRA-affected BRI (58231826).
Focusing on the ABCA4 coding region only, 16 of the 31 observed haplotypes were present
exclusively in affected dogs (Suppl. Table 3; haplotypes 1, 6–9, 16, 17, 19–23, 28–31); the
most common one having a frequency of 7.9% (16). To this end, no significant difference was
found between affected and non-affected individuals (p = 0.918 ± 0.009) in a global AMOVA
analysis, nor did any single polymorphism show significant difference between these two
groups in the locus-by-locus analysis. However, two PRA-affected dogs, GIT and GSP, were
homozygous for one of those haplotypes, while another 5 individuals, two BAS, BRI, SCW,
and SSD, were compound heterozygotes for different haplotype combinations. Although these
results could result from a bias of PRA-affected animals and breeds, haplotypes specific to
diseased animals could potentially contribute to modifying and/or complex inherited disease
traits.
Discussion
Rapid advancements in identification and screening for sequence variations has contributed
greatly to the definition of population structure and increased our ability to start teasing out
genetic interaction and modification determining phenotypic expression of variable traits.
While the ABCA4 mutation database
(http://www.retina-international.org/sci-news/abcrmut.htm) lists several hundred observed
changes, only few have been reproducibly associated with distinct disease phenotypes in
patients. In fact, many times the development of clinical disorders is ascribed to a combination
of gene modifications (Klevering et al. 2002). Despite all efforts to develop suitable model
systems addressing genotype–phenotype correlations, as well as offering insights into disease
mechanisms, the current limitations of small sample sizes for human cohorts, small animal
models, and in vitro studies have yet to be overcome.
Attempts to identify a large animal model are often based on linkage analysis in well
characterized pedigrees (Kijas et al. 2004; Wiik et al. 2008). In recent years, these elaborate
methods are being replaced by time and cost-effective screening methods. A study
investigating ABCA4 in 25 dog breeds affected with PRA identified 18 sequence variants,
including a single aa change, by SSCP (Lippmann et al. 2006). ABCA4 was excluded as
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causative gene for PRA in 17 breeds, but could not be assessed in the remainder. Lack of in-
depth sequence variation, however, not only compromises exclusion of some breeds, but also
negates deductions of prospective markers and/or test sets. To overcome these limitations, we
significantly increased our knowledge of variability and potential haplotype structure of the
canine ABCA4 through DNA sequencing of 38 individual dogs from 26 breeds (Table 1), which
resulted in the overall identification of 88 polymorphisms in exons and surrounding intronic
sequence (Suppl. Table 2). A threefold increased mutation rate in the ABCA4 non-coding
region, as well as the 2.5 times bias towards transitions than transversions, rejects
predisposition to a particular mutation mechanism or hotspot throughout the genomic
ABCA4 region. Thus, a reasonably predictive tag marker set could be developed utilizing 17
or 15 SNPs sufficient to recognize >85% and >80%, respectively, of the observed genomic
diversity at this locus (Table 2, Suppl. figure 1), and will facilitate future population and/or
association studies of ABCA4.
Most variability is observed within the 5′ region of the gene (Suppl. figure 1), without indication
that this is related to regulatory function. Despite the lower number of haplotypes in and around
3′ exons, the total amount of polymorphisms is higher due to accumulation of multiple rare
variants in few breeds (e.g. AKI, BAS, ADT). One could propose that this is a result of stronger
influence of negative selection and genetic drift to eliminate potentially harmful haplotypes,
or differences in local recombination rates, irrespective of the location of predicted
transmembrane and nucleotide binding domains. It should be pointed out that these rare
haplotypes appear more commonly in presumed “ancient” dog breeds, e.g. BAS, AKI, or HUS
(Vonholdt et al. 2010). Variations shared between breeds that typically do not cluster based on
large genomic data sets (Parker et al. 2004) may hint at more recent breed admixture (BAS
and BMD), or result from geographic proximity of the breed origin (SSD and ADT). The
inability of the genetic variation to differentiate breeds or affected animals in the current data
set is likely due to the small number of animals/breeds sequenced. However, rare, but breed-
specific alleles, can now be utilized to address focused questions in the respective breeds.
Non-coding sequence variants were excluded from simple Mendelian disease association based
on segregation in the affected animals or allele frequency in the breed (7% BMD; 70% GSP)
under the assumption of autosomal recessive disease models. Comparable to few frequent
haplotypes (>10%) observed within the complete data set (2–4 in Suppl. figure 1), 17
polymorphisms located within the ABCA4 coding region account for a single common
chromosome (Suppl. Table 3, haplotype 14). The vast majority of minor frequency haplotypes
is private to specific breeds and/or individuals; therefore, their relevance to gene function
cannot be deduced at this time. These haplotypes encompass five missense mutations (Suppl.
Table 3, alternative alleles underlined), three of which (58168353, 58198327, 58216455) were
excluded from disease association in the current and previous models (Kijas et al. 2004).
Despite the potential molecular consequences of 58168353 and 58198327, they are not located
within structural or functional domains, such as predicted ABC transmembrane domain (TD),
nucleotide binding domains (NBD) or glycosylation sites. On the other hand, 58216455,
located within a putative TD, is a conservative change with the mutant allele common in other
species (Table 3). One of the remaining mutations, 58180284 (BICF2P1361455), was not
identified within known domains or a functional site, nor did the segregation within our sample
set (26% allele frequency) or previous studies (Lindblad-Toh et al. 2005) support pathogenic
potential. The non-conservative Arg1539Gly change (58207091), however, is correlated with
a putative topological domain, and appears to affect a highly conserved site (Table 3, human,
rhesus). Although the mutant allele has a higher frequency in normal versus affected animals,
we cannot satisfactorily conclude form the current data that the variant by itself, or in
combination with other nucleotide changes in ABCA4 may contribute to a genetic load that
serves as negative or protective modifier of retinal diseases, which could particularly benefit
such breeds as MLD with other known molecular defects. Our work should provide a
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foundation to further evaluate such effects. Interestingly, contrary to recent suggestions from
comparative data (Gibbs et al. 2007), we did not find a bias of the human ABCA4 protein
towards potentially disease-causing variants based on our data set, but this could simply
indicate that none of the sequence changes found have an impact on retinal disorders.
Given the high incidence of ABCA4-associated disease in humans, the lack of association
between sequence variations and retinal disorders in canines is rather surprising, particularly
considering the high conservation of both the gene and the polymorphic coding sites (Table
3). Our results raise the question as to whether the association between retinal disease and
sequence variations observed in only one or a few human patients might be associated with
rare alleles rather than disease (Stone 2007). Alternatively, disadvantageous polymorphisms
might not readily lead to a disease phenotype in the dog. It also has to be pointed out that
ABCA4 disease involving the macula in human patients (Cideciyan et al. 2005) may manifest
differently in non-primate species missing this characteristic formation of rod/cone
arrangements. Recent studies suggest that such structural aspects could significantly contribute
to species variation and even alter the mode of inheritance for some disease models (Guziewicz
et al. 2007).
We anticipate that our study will lead the way to an efficient and in-depth screening of the
ABCA4 gene in a variety of canine populations. This will enable the rapid identification of
individuals with potential mutations in this gene, and also provide insight into the influence of
ABCA4 haplotypes on retinal disease. Such steps are essential for the advancement of
comparative genomic approaches, and the suitable study of pedigrees to address phenotype–
genotype correlations at this highly variable locus.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors would like to thank Sue Pearce-Kelling for support and coordination of research samples, and James Kijas
for methodical and inspirational comments. The work was supported by The Foundation Fighting Blindness Center
and Individual Investigator grants; Morris Animal Foundation; NEI/NIH grants EY-06855, -017549 (The content is
solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute
or the National Institutes of Health); the Van Sloun Fund for Canine Genetic Research; Vision Research Center grant
P30 EY-001583; Hope for Vision Foundation; The ONCE International Prize for R&D in Biomedicine and New
Technologies for the Blind.
References
Aguirre, GD.; Acland, GM. Models, mutants and man: searching for unique phenotypes and genes in the
dog model of inherited retinal degeneration. In: Ostrander, EA.; Giger, U.; Lindblad-Toh, K., editors.
The Dog and its genome. Cold Spring Harbor Laboratory Press; Cold Spring Harbor: 2006. p. 291-325.
Albrecht C, Viturro E. The ABCA subfamily-gene and protein structures, functions and associated
hereditary diseases. Pflugers Arch 2007;453(5):581–589. [PubMed: 16586097]
Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y,
Huchinson A, Dean M, Lupske JR, Lappert M. Mutation of the Stargardt disease gene (ABCR) in age-
related macular degeneration. Science 1997;277(5333):1805–1807. [PubMed: 9295268]
Cideciyan AV, Swider M, Aleman TS, Sumaroka A, Schwartz SB, Roman MI, Milam AH, Bennett J,
Stone EM, Jacobson SG. ABCA4-associated retinal degenerations spare structure and function of the
human parapapillary retina. Invest Ophthalmol Vis 2005;46(12):4739–4746.
Cideciyan AV, Swider M, Aleman TS, Tsybovsky Y, Schwartz SB, Windsor E, Roman AJ, Sumaroka
A, Steinberg JD, Jacobson SG, Stone EM, Palczewski K. ABCA4 disease progression and a proposed
strategy for gene therapy. Hum Mol Genet 2009;18(5):931–941. [PubMed: 19074458]
Zangerl et al. Page 7
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
Cremers FP, van de Pol DJ, van Driel M, den Hollander AI, van Haren FJ, Knoers NV, Tijmes N, Bergen
AA, Rohrschneider K, Blankenagel A, Pinckers AJ, Deutman AF, Hoyng CB. Autosomal recessive
retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease
gene ABCR. Hum Mol Genet 1998;7(3):355–362. [PubMed: 9466990]
Ducroq D, Rozet JM, Gerber S, Perrault I, Barbet D, Hanein S, Hakiki S, Dufier JL, Munnich A, Hamel
C, Kaplan J. The ABCA4 gene in autosomal recessive cone-rod dystrophies. Am J Hum Genet 2002;71
(6):1480–1482. [PubMed: 12515255]
Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: an integrated software package for population
genetics data analysis. Evol Bioinform Online 2005;1:47–50. [PubMed: 19325852]
Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, Remington KA, Strausberg
RL, Venter JC, Wilson RK, et al. Evolutionary and biomedical insights from the rhesus macaque
genome. Science 2007;316(5822):222–234. [PubMed: 17431167]
Guziewicz KE, Zangerl B, Lindauer SJ, Mullins RF, Sandmeyer LS, Grahn BH, Stone EM, Acland GM,
Aguirre GD. Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model
for best disease. Invest Ophthalmol Vis Sci 2007;48(5):1959–1967. [PubMed: 17460247]
Holland, IB.; Cole, SPC.; Kuchler, K.; Higgins, CF. ABC Proteins. Elsevier Science Ltd.; London: 2003.
Kijas JW, Zangerl B, Miller B, Nelson J, Kirkness EF, Aguirre GD, Acland GM. Cloning of the canine
ABCA4 gene and evaluation in canine cone-rod dystrophies and progressive retinal atrophies. Mol
Vis 2004;10:223–232. [PubMed: 15064680]
Kitiratschky VB, Grau T, Bernd A, Zrenner E, Jagle H, Renner AB, Kellner U, Rudolph G, Jacobson
SG, Cideciyan AV, Schaich S, Kohl S, Wissinger B. ABCA4 gene analysis in patients with autosomal
recessive cone and cone rod dystrophies. Eur J Hum Genet 2008;16(7):812–819. [PubMed:
18285826]
Klevering BJ, Blankenagel A, Maugeri A, Cremers FP, Hoyng CB, Rohrschneider K. Phenotypic
spectrum of autosomal recessive cone-rod dystrophies caused by mutations in the ABCA4 (ABCR)
gene. Invest Ophthalmol Vis Sci 2002;43(6):1980–1985. [PubMed: 12037008]
Klevering BJ, Deutman AF, Maugeri A, Cremers FP, Hoyng CB. The spectrum of retinal phenotypes
caused by mutations in the ABCA4 gene. Graefes Arch Clin Exp Ophthalmol 2005;243(2):90–100.
[PubMed: 15614537]
Kukekova AV, Goldstein O, Johnson JL, Richardson MA, Pearce-Kelling SE, Swaroop A, Friedman JS,
Aguirre GD, Acland GM. Canine RD3 mutation establishes rod-cone dysplasia type 2 (rcd2) as
ortholog of human and murine rd3. Mamm Genome 2009;20(2):109–123. [PubMed: 19130129]
Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, Clamp M, Chang JL,
Kulbokas EJ, Zody MC, et al. Genome sequence, comparative analysis and haplotype structure of
the domestic dog. Nature 2005;438(7069):803–819. [PubMed: 16341006]
Lippmann T, Pasternack SM, Kraczyk B, Dudek SE, Dekomien G. Indirect exclusion of four candidate
genes for generalized progressive retinal atrophy in several breeds of dogs. J Negat Results Biomed
2006;5:19. [PubMed: 17134500]
Liu J, Lu W, Reigada D, Nguyen J, Laties AM, Mitchell CH. Restoration of lysosomal pH in RPE cells
from cultured human and ABCA4−/− mice: pharmacologic approaches and functional recovery.
Invest Ophthalmol Vis Sci 2008;49(2):772–780. [PubMed: 18235027]
Mellersh CS, Boursnell ME, Pettitt L, Ryder EJ, Homes NG, Grafham D, Forman OP, Sampson J, Barnett
KC, Blanton S, Binns MM, Vaudin M. Canine RPGRIP1 mutation establishes cone-rod dystrophy
in miniature longhaired dachshunds as a homologue of human Leber congenital amaurosis. Genomics
2006;88(3):293–301. [PubMed: 16806805]
Molday RS, Zhong M, Quazi F. The role of the photoreceptor ABC transporter ABCA4 in lipid transport
and Stargardt macular degeneration. Biochim Biophys Acta 2009;1791(7):573–583. [PubMed:
19230850]
Parker HG, Kim LV, Sutter NB, Carlson S, Lorentzen TD, Malek TB, Johnson GS, DeFrance HB,
Ostrander EA, Kruglyak L. Genetic structure of the purebred domestic dog. Science 2004;304(5674):
1160–1164. [PubMed: 15155949]
Quignon P, Herbin L, Cadieu E, Kirkness EF, Hedan B, Mosher DS, Galibert F, Andre C, Ostrander EA,
Hitte C. Canine population structure: assessment and impact of intra-breed stratification on SNP-
based association studies. PLoS ONE 2007;2(12):e1324. [PubMed: 18091995]
Zangerl et al. Page 8
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits
lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl
Acad Sci USA 2003;100(8):4742–4747. [PubMed: 12671074]
Radu RA, Yuan Q, Hu J, Peng JH, Lloyd M, Nusinowitz S, Bok D, Travis GH. Accelerated accumulation
of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies
following Vitamin A supplementation. Invest Ophthalmol Vis Sci 2008;49(9):3821–3829. [PubMed:
18515570]
Shroyer NF, Lewis RA, Yatsenko AN, Wensel TG, Lupski JR. Cosegregation and functional analysis of
mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related
macular degeneration. Hum Mol Genet 2001;10(23):2671–2678. [PubMed: 11726554]
Stone EM. Finding and interpreting genetic variations that are important to ophthalmologists. Trans Am
Ophthalmol Soc 2003;101:437–484. [PubMed: 14971589]
Stone EM. Genetic testing for inherited eye disease. Arch Ophthalmol 2007;125(2):205–212. [PubMed:
17296896]
Suber ML, Pittler SJ, Qin N, Wright GC, Holcombe V, Lee RH, Craft CM, Lolley RN, Baehr W, Hurwitz
RL. Irish setter dogs affected with rod/cone dysplasia contain a nonsense mutation in the rod cGMP
phosphodiesterase beta-subunit gene. Proc Natl Acad Sci USA 1993;90:3968–3972. [PubMed:
8387203]
Sun H, Nathans J. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments. Nat
Genet 1997;17(1):15–16. [PubMed: 9288089]
Sun H, Nathans J. Mechanistic studies of ABCR, the ABC transporter in photoreceptor outer segments
responsible for autosomal recessive Stargardt disease. J Bioenerg Biomembr 2001;33(6):523–530.
[PubMed: 11804194]
Sun H, Molday RS, Nathans J. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR,
the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J Biol
Chem 1999;274(12):8269–8281. [PubMed: 10075733]
Sun H, Smallwood PM, Nathans J. Biochemical defects in ABCR protein variants associated with human
retinopathies. Nat Genet 2000;26(2):242–246. [PubMed: 11017087]
Vonholdt BM, Pollinger JP, Lohmueller KE, Han E, Parker HG, Quignon P, Degenhardt JD, Boyko AR,
Earl DA, Auton A, et al. Genome-wide SNP and haplotype analyses reveal a rich history underlying
dog domestication. Nature 2010;464(7290):898–902. [PubMed: 20237475]
Webster AR, Heon E, Lotery AJ, Vandenburth K, Casavant TL, Oh KT, Beck G, Fishman GA, Lam BL,
Levin A, et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 2001;42
(6):1179–1189. [PubMed: 11328725]
Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of Rim
protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout
mice. Cell 1999;98(1):13–23. [PubMed: 10412977]
Wiik AC, Ropstad EO, Bjerkas E, Lingaas F. A study of candidate genes for day blindness in the standard
wire haired dachshund. BMC Vet Res 2008;4:23. [PubMed: 18593457]
Zangerl B, Goldstein O, Philp AR, Lindauer SJ, Pearce-Kelling SE, Mullins RF, Graphodatsky AS, Ripoll
D, Felix JS, Stone EM, Acland GM, Aguirre GD. Identical mutation in a novel retinal gene causes
progressive rod-cone degeneration in dogs and retinitis pigmentosa in humans. Genomics 2006;88
(5):551–563. [PubMed: 16938425]
Zhang K, Qin Z, Chen T, Liu JS, Waterman MS, Sun F. HapBlock: haplotype block partitioning and tag
SNP selection software using a set of dynamic programming algorithms. Bioinformatics 2005;21(1):
131–134. [PubMed: 15333454]
Zangerl et al. Page 9
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
Zangerl et al. Page 10
Ta
bl
e 
1
PR
A
-a
ff
ec
te
d 
an
d 
co
nt
ro
l d
og
s b
y 
br
ee
d 
us
ed
 in
 p
re
se
nt
 st
ud
y
B
re
ed
 d
at
a
D
og
s a
ffe
ct
ed
D
og
s n
ot
 a
ffe
ct
ed
B
re
ed
M
od
e 
of
 in
he
ri
ta
nc
e
A
ge
 (y
ea
rs
)
Se
x
A
ge
 (y
ea
rs
)
Se
x
A
D
T:
 A
ire
da
le
 te
rr
ie
r
N
o 
lit
er
at
ur
e
2.
5
F
2.
2
F
A
K
I: 
A
ki
ta
A
ut
os
om
al
 re
ce
ss
iv
e
N
/A
M
N
/A
M
B
A
S:
 B
as
en
ji
N
ot
 d
ef
in
ed
6.
8
F
11
.7
M
N
/A
M
B
M
D
: B
er
ne
se
 m
ou
nt
ai
n 
do
g
N
ot
 d
ef
in
ed
8
F
8.
7
M
B
O
T:
 B
os
to
n 
te
rr
ie
r
N
o 
lit
er
at
ur
e
–
–
4.
3
F
B
R
I: 
B
ria
rd
A
ut
os
om
al
 re
ce
ss
iv
e
12
F
–
–
B
U
M
: B
ul
lm
as
tif
f
A
ut
os
om
al
 re
ce
ss
iv
e
2.
6
F
–
–
C
C
R
: C
ur
ly
 c
oa
te
d 
re
tri
ev
er
N
ot
 d
ef
in
ed
5.
3
M
–
–
EM
D
: E
st
el
la
 m
ou
nt
ai
n 
do
g
N
ot
 d
ef
in
ed
0.
4
F
–
–
ES
S:
 E
ng
lis
h 
sp
rin
ge
r s
pa
ni
el
A
ut
os
om
al
 re
ce
ss
iv
e
7.
8
M
–
–
G
IT
: G
le
n 
of
 Im
aa
l t
er
rie
r
N
ot
 d
ef
in
ed
8
M
N
/A
F
G
O
S:
 G
or
do
n 
se
tte
r
A
ut
os
om
al
 re
ce
ss
iv
e
7.
1
M
–
–
G
SH
: G
er
m
an
 sh
ep
he
rd
A
ut
os
om
al
 re
ce
ss
iv
e
7.
5
M
–
–
G
SP
: G
er
m
an
 sh
or
th
ai
re
d 
po
in
te
r
A
ut
os
om
al
 re
ce
ss
iv
e
2.
5
F
–
–
H
U
S:
 S
ib
er
ia
n 
hu
sk
y
X
-li
nk
ed
–
–
2.
7
M
3.
5
M
IG
H
: I
ta
lia
n 
gr
ey
ho
un
d
N
ot
 d
ef
in
ed
3
M
10
F
M
LD
: D
ac
hs
hu
nd
, m
in
ia
tu
re
 lo
ng
ha
ire
da
A
ut
os
om
al
 re
ce
ss
iv
e
11
F
–
–
M
SH
: S
ch
na
uz
er
, m
in
ia
tu
re
A
ut
os
om
al
 re
ce
ss
iv
e
0.
8
M
–
–
3.
1
F
N
/A
F
O
ES
: O
ld
 E
ng
lis
h 
sh
ee
pd
og
N
ot
 d
ef
in
ed
6.
1
M
–
–
PA
P:
 P
ap
ill
on
A
ut
os
om
al
 re
ce
ss
iv
e
5
F
7
F
R
O
T:
 R
ot
tw
ei
le
r
N
ot
 d
ef
in
ed
7.
5
M
–
–
R
R
B
: R
ho
de
si
an
 ri
dg
eb
ac
k
N
o 
lit
er
at
ur
e
–
–
N
/A
N
/A
SC
W
: S
of
t c
oa
te
d 
w
he
at
en
 te
rr
ie
r
N
o 
lit
er
at
ur
e
5
M
–
–
SS
D
: S
he
tla
nd
 sh
ee
pd
og
N
ot
 d
ef
in
ed
8
M
–
–
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
Zangerl et al. Page 11
B
re
ed
 d
at
a
D
og
s a
ffe
ct
ed
D
og
s n
ot
 a
ffe
ct
ed
B
re
ed
M
od
e 
of
 in
he
ri
ta
nc
e
A
ge
 (y
ea
rs
)
Se
x
A
ge
 (y
ea
rs
)
Se
x
TI
S:
 T
ib
et
an
 sp
an
ie
l
A
ut
os
om
al
 re
ce
ss
iv
e
4.
2
M
–
–
TT
: T
ib
et
an
 te
rr
ie
r
A
ut
os
om
al
 re
ce
ss
iv
e
4.
8
M
11
.8
F
N
ot
e 
th
at
 a
ni
m
al
s f
or
 w
hi
ch
 e
xa
ct
 a
ge
 is
 n
ot
 a
va
ila
bl
e 
ex
ce
ed
ed
 th
e 
br
ee
d 
ty
pi
ca
l a
ge
 o
f o
ns
et
 fo
r d
is
ea
se
a T
hi
s a
ni
m
al
 is
 h
om
oz
yg
ou
s a
ff
ec
te
d 
fo
r a
 d
el
et
io
n 
in
 R
PG
RI
P1
 (M
el
le
rs
h 
et
 a
l. 
20
06
)
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
Zangerl et al. Page 12
Ta
bl
e 
2
B
as
ed
 o
n 
ob
se
rv
ed
 al
le
le
 fr
eq
ue
nc
ie
s i
n 
th
e p
re
se
nt
ed
 d
at
a s
et
, a
 m
in
im
um
 re
co
m
m
en
de
d 
sc
re
en
in
g 
se
t o
f 1
7 
po
ly
m
or
ph
ic
 m
ar
ke
rs
 is
 su
gg
es
te
d,
 w
hi
ch
 al
lo
w
s
id
en
tif
ic
at
io
n 
of
 o
ve
r 8
5%
 o
f a
ll 
ha
pl
ot
yp
es
 p
re
se
nt
 a
t m
or
e 
th
an
 5
%
 fr
eq
ue
nc
y 
in
 th
e 
ov
er
al
l d
og
 p
op
ul
at
io
n
L
oc
at
io
n
SN
P
A
lle
le
s/
Fr
eq
ue
nc
y
C
G
D
G
en
e
C
G
D
A
lte
rn
at
iv
e
58
11
28
73
5′
U
TR
B
IC
F2
P6
67
77
7
G
A
0.
71
58
11
29
55
5′
U
TR
B
IC
F2
P6
67
77
8
G
A
0.
37
58
12
08
73
In
tro
n 
1
B
IC
F2
P2
79
47
0
T
C
0.
20
58
12
40
46
In
tro
n 
3
N
C
B
I_
ss
# 
24
42
42
17
3
T
–
0.
20
58
12
41
94
Ex
on
 4
B
IC
F2
P8
14
23
9
T
C
0.
54
58
13
40
85
Ex
on
 6
N
C
B
I_
ss
# 
24
42
42
17
7
T
A
0.
43
58
13
43
79
In
tro
n 
6
N
C
B
I_
ss
# 
24
42
42
17
9
A
G
0.
13
58
14
81
38
In
tro
n 
7
N
C
B
I_
ss
# 
24
42
42
18
1
T
A
0.
75
58
15
19
28
In
tro
n 
9
B
IC
F2
P6
62
49
1
C
T
0.
08
58
16
83
53
Ex
on
 1
3
B
IC
F2
P5
30
46
0
A
C
0.
47
58
16
84
36
In
tro
n 
13
N
C
B
I_
ss
# 
24
42
42
18
9
T
A
0.
16
58
18
02
84
Ex
on
 1
7
B
IC
F2
P1
36
14
55
G
C
0.
74
58
18
31
06
In
tro
n 
18
B
IC
F2
P1
36
14
64
A
G
0.
59
58
19
42
54
In
tro
n 
25
B
IC
F2
P8
08
83
2
C
G
0.
58
58
20
26
94
Ex
on
 3
0
B
IC
F2
P6
48
36
G
A
0.
59
58
20
70
91
Ex
on
 3
1
N
C
B
I_
ss
# 
24
42
42
21
4
G
A
0.
17
58
22
38
70
In
tro
n 
41
B
IC
F2
P1
38
00
19
A
G
0.
71
Th
e 
m
in
im
um
 sc
re
en
in
g 
se
t c
an
 b
e 
re
du
ce
d 
to
 1
5 
m
ar
ke
rs
 fo
r r
el
ia
bl
e 
re
co
gn
iti
on
 o
f 8
0%
 o
f a
ll 
ha
pl
ot
yp
es
 b
y 
el
im
in
at
in
g 
B
IC
F2
P8
08
83
2 
an
d 
B
IC
F2
P6
48
36
 (b
ol
d)
. P
os
iti
on
 o
f t
he
 re
sp
ec
tiv
e 
m
ar
ke
rs
 is
in
di
ca
te
d 
by
 th
e 
ge
no
m
ic
 lo
ca
tio
n 
on
 C
FA
6 
[c
an
in
e 
ge
no
m
e 
dr
af
t (
C
G
D
), 
ve
rs
io
n 
M
ay
 2
00
5]
 a
nd
 re
sp
ec
tiv
e 
lo
ca
tio
n 
w
ith
in
 th
e 
ge
ne
 st
ru
ct
ur
e 
(G
en
e)
. N
om
en
cl
at
ur
e 
re
fle
ct
s e
ith
er
 in
cl
us
io
n 
in
 th
e 
pr
ev
io
us
ly
pu
bl
is
he
d 
ca
ni
ne
 S
N
P 
se
t (
Li
nd
bl
ad
-T
oh
 e
t a
l. 
20
05
) o
r d
bS
N
P 
ac
ce
ss
io
n 
nu
m
be
r
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
Zangerl et al. Page 13
Ta
bl
e 
3
N
uc
le
ot
id
e 
ch
an
ge
s o
bs
er
ve
d 
in
 c
an
in
e 
AB
C
A4
 c
od
in
g 
re
gi
on
 a
nd
 c
om
pa
ris
on
 to
 th
e 
hu
m
an
 (N
M
_0
00
35
0)
 a
nd
 rh
es
us
 m
ac
aq
ue
 (X
R
_0
12
91
9.
1)
 g
en
e
C
an
in
e 
AB
CA
4
H
um
an
 A
BC
A4
R
he
su
s A
BC
A4
L
oc
at
io
na
E
xo
n
N
uc
le
ot
id
e 
ch
an
ge
aa
N
uc
le
ot
id
e
aa
N
uc
le
ot
id
e
aa
58
12
41
94
4
c.
30
3 
T 
> 
C
Th
r1
01
Th
r
C
Th
r1
01
C
Th
r1
01
58
12
43
32
4
c.
44
1 
G
 >
 A
A
la
14
7A
la
A
A
la
14
7
A
A
la
14
7
58
13
40
85
6
c.
58
8 
T 
> 
A
Pr
o1
96
Pr
o
G
Pr
o1
96
G
Pr
o1
96
58
15
03
51
8
c.
86
7 
T 
> 
C
H
is
28
9H
is
T
H
is
28
9
T
A
rg
28
9
58
16
74
25
12
c.
15
81
 C
 >
 T
Se
r5
27
Se
r
C
Se
r5
27
C
Se
r5
27
58
16
83
53
13
c.
18
80
 A
 >
 C
G
lu
62
7A
la
A
G
lu
62
7
A
G
lu
62
7
58
18
02
84
17
c.
26
02
 C
 >
 G
Pr
o8
68
A
la
C
Pr
o8
68
C
Pr
o8
68
58
19
83
27
27
c.
39
58
 G
 >
 A
A
la
13
20
T
hr
C
Pr
o1
32
2
C
Pr
o1
32
2
58
20
16
57
29
c.
42
54
 A
 >
 G
Pr
o1
41
8P
ro
A
Pr
o1
42
2
G
Pr
o1
42
2
58
20
16
66
29
c.
42
63
 G
 >
 A
G
lu
14
21
G
lu
G
G
lu
14
25
G
G
lu
14
25
58
20
16
75
29
c.
42
72
 A
 >
 G
A
la
14
24
A
la
G
T
hr
14
28
G
T
hr
14
28
58
20
25
89
30
c.
43
68
 T
 >
 C
Pr
o1
45
6P
ro
C
Pr
o1
46
0
C
Pr
o1
46
0
58
20
26
94
30
c.
44
73
 G
 >
 A
Ly
s1
49
1L
ys
G
Ly
s1
49
5
G
Ly
s1
49
5
58
20
27
18
30
c.
44
97
 T
 >
 C
Pr
o1
49
9P
ro
C
Pr
o1
50
3
C
Pr
o1
50
3
58
20
70
23
31
c.
45
48
 A
 >
 G
G
lu
15
16
G
lu
A
G
lu
15
20
A
G
lu
15
20
58
20
70
91
31
c.
46
16
 G
 >
 A
A
rg
15
39
G
ln
G
A
rg
15
43
G
A
rg
15
43
58
21
64
55
37
c.
52
27
 G
 >
 A
V
al
17
43
Il
e
A
Ile
17
47
A
Ile
17
47
C
ha
ng
es
 le
ad
in
g 
to
 su
bs
tit
ut
io
ns
 in
 th
e 
am
in
o 
ac
id
 (a
a)
 se
qu
en
ce
 a
re
 h
ig
hl
ig
ht
ed
a B
as
ed
 o
n 
C
FA
6 
of
 U
C
SC
 se
rv
er
 c
an
in
e 
ge
no
m
ic
 se
qu
en
ce
 v
. M
ay
 2
00
5 
(h
ttp
://
ge
no
m
e.
uc
sc
.e
du
/)
Mol Genet Genomics. Author manuscript; available in PMC 2010 October 14.
